Q1 2025 Management View CEO Chip Blankenship highlighted robust demand in core industrial and aerospace segments despite a slight year-over-year decline in overall results. He emphasized operational ...

For each 5 percentage point increase in the U.S. tariff rate, the S&P 500 (SP500) EPS would reduce by 1-2%, said David Kostin, chief U.S. equity strategist at Goldman Sachs, in a note. A sustained 25% ...

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

Despite a sharp tech sell-off earlier this week sparked by the launch of Chinese startup DeepSeek's AI model, major market ...

Reports Q1 revenue $4.01B, consensus $4.11B. “Trends across our markets remain robust, and our backlog and pipeline are at record levels, ...

In the twisty procedural drama "The Hunting Party," a team of investigators must round up escaped serial killers after a huge ...

Novartis reported strong Q4 earnings and sales growth, with CEO Narasimhan reportedly downplaying concerns over Entresto's ...

B, consensus $3.41B. Backs FY25 capital expenditures view $115M. Backs FY25 free cash flow view $350M-$400M. The company said, W ...

Broadridge Financial Solutions delivered impressive second-quarter results, beating both revenue and earnings expectations.

Dover Corporation (NYSE:DOV) shares are trading higher on Thursday after the company reported fourth-quarter results. Revenue ...

Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...